About Prostate Cancer Research
Prostate Cancer Research (PCR) is a research and information provision charity that is dedicated to improving and saving the lives of people with prostate cancer. Patients are central to everything we do and drive our work. Our work covers four key areas:
- Academic and social research – We fund novel and innovative research projects at world-leading institutions that are working towards breakthroughs in the prevention, diagnosis and treatment of advanced prostate cancer, and better quality of life outcomes for patients. We ensure that our research is targeted to address patient need and research gaps to maximise our impact and reach better treatments for patients sooner.
- Translational research – We set up Proven Connect, the translational research arm of PCR, to focus on ensuring more promising treatments get from lab to patient through bridging the gap between industry, investors, health providers and patients.
- Patient information and empowerment – We acknowledge that research alone is not enough to achieve our vision. We involve, educate, and empower people affected by prostate cancer to enable them to play a more active role in driving forward changes in research, treatment and care.
- Influencing – We seek to ensure greater equity of treatment and parity of care, and are working towards a world where no man is left behind, where prostate cancer is caught early and can be cured.
Our vision for the future is clear: to be an integral part of creating one of the healthiest ecosystems for any disease type. An ecosystem that is connected, collaborative, equitable, and effective. Over the next 3 years we are setting ambitious targets to double our research funding, accelerate twelve biotech ventures, engage at least 100,000 people in influencing change, initiate three novel projects to enhance equity, and grow our income to more than £7 million.
For more information visit www.pcr.org.uk and www.theinfopool.co.uk